Search

everythinglearnresearchcommunity

for

Search:↓

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

MK-5108 is safe and shows potential against tumors, especially alone.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

The study found that baicalin has different stable shapes in gas and water, with two shapes better for interacting with positive charges in water.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Bortezomib chemotherapy can cause temporary skin rashes.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Liposomal formulations with caffeine and cafestol enhance skin penetration effectively.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Tofacitinib might be used to treat hair loss.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

Cirsium japonicum flower extract increases melanin production and could help treat depigmentation conditions.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.